Symbols
Symbols
Aime
Products
News
Markets
Watchlist
Brokers
US Stocks
/
VYGR
/
revenue
V
VYGR
EPS
Revenue & Expenses
How did Voyager Therapeutics' revenue and expenses shift in Q4 2024?
Ask Aime more questions
